ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
Status:
Recruiting
Trial end date:
2021-10-29
Target enrollment:
Participant gender:
Summary
This is a phase 3, multi-center, single dose, open-label, exploratory study in suspected lung
cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/PET/MRI or other
imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near
Infrared Imaging (NIR) at identifying pulmonary nodules within the operating theater, and to
assess the safety and tolerability of single intravenous doses of OTL38.